1.Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1.
Qiu-su TANG ; Xiao-dong TENG ; Wei DING ; Jie ZHOU ; Hong-tian YAO ; Li-xiong YING ; Li-ming XU
Chinese Journal of Pathology 2011;40(11):745-748
OBJECTIVETo study immunohistochemical expression of GADD153 and assess its usefulness as markers in the differential diagnoses in follicular tumors of the thyroid.
METHODSImmunohistochemical staining was performed on formalin-fixed paraffin-embedded tissue of 34 cases of follicular thyroid adenomas (FTA), 46 cases of follicular thyroid carcinomas (FTC), 29 cases of follicular variant papillary carcinomas (FVPC).
RESULTS(1) GADD153 was expressed in cell nucleus with positive or strong positive expression in FTC, and no or weak expression in FTA and FVPC. The positive expressions of GADD153 were present in 38 of 46(82.6%) in FTC, 11 of 34(32.4%) in FTA and three of 29(10.3%) in FVPC, the positive expression rate in FTC was obviously higher than that in FTA and in FVPC, the differences were statistically significant (χ² = 20.80 and 37.48; P < 0.01). (2) CK19, Galectin-3 (Gal-3) and HBME-1 were all expressed in the cytoplasm, the positive expressions of CK19, Gal-3 and HBME-1 were present in 54.3% (25/46), 67.4% (31/46) and 58.7% (27/46) in FTC; 50.0% (17/34), 29.4% (10/34) and 32.4% (11/34) in FTA; 100% (29/29), 93.1% (27/29) and 89.7% (26/29) in FVPC, the differences were statistically significant as well (χ² = 21.20 and 8.22; P < 0.01). (3) According to the expressions of CK19, Gal-3, HBME-1 and GADD153, we divided the results into low expression group (0 or 1+) and high expression group (2+ or 3+), the sensitivity and the specificity were calculated. in FTA, the sensitivity were 26.5%, 8.8%, 2.9% and 11.8%; the specificity were 50.7%, 52.0%, 54.7% and 58.7%. in FTC, the sensitivity were 19.6%, 26.1%, 23.9% and 65.2%; the specificity were 41.3%, 57.1%, 62.0% and 92.1%. in FVPC, the sensitivity were 96.6%, 82.8%, 79.3% and 3.4%; the specificity were 77.5%, 81.3%, 85.0% and 57.5%.
CONCLUSIONSThe sensitivity and the specificity of GADD153 expression are well for diagnosing FTC, and CK19, Gal-3, HBME-1 are well for FVPC. The four markers when used in combination, are better to identify the follicular tumors of the thyroid.
Adenocarcinoma, Follicular ; diagnosis ; metabolism ; pathology ; Adenoma ; diagnosis ; metabolism ; pathology ; Biomarkers, Tumor ; metabolism ; Carcinoma, Papillary, Follicular ; diagnosis ; metabolism ; pathology ; Diagnosis, Differential ; Galectin 3 ; metabolism ; Humans ; Keratin-19 ; metabolism ; Sensitivity and Specificity ; Thyroid Neoplasms ; diagnosis ; metabolism ; pathology ; Transcription Factor CHOP ; metabolism
2.Problems in pathologic diagnosis of thyroid follicular cell carcinoma.
Chinese Journal of Pathology 2014;43(5):348-352
Adenocarcinoma, Follicular
;
classification
;
metabolism
;
pathology
;
Adenoma
;
metabolism
;
pathology
;
Biomarkers, Tumor
;
metabolism
;
Carcinoma, Papillary
;
metabolism
;
pathology
;
Diagnosis, Differential
;
Humans
;
Signal Transduction
;
Thyroid Neoplasms
;
classification
;
metabolism
;
pathology
3.Thyroid follicular carcinoma-like renal cell carcinoma: report of a case.
Chinese Journal of Pathology 2013;42(9):622-623
Adenocarcinoma, Follicular
;
Adult
;
Carcinoid Tumor
;
metabolism
;
pathology
;
Carcinoma, Renal Cell
;
metabolism
;
pathology
;
surgery
;
Diagnosis, Differential
;
Female
;
Humans
;
Keratin-7
;
metabolism
;
Kidney Neoplasms
;
metabolism
;
pathology
;
surgery
;
Mucin-1
;
metabolism
4.Bronchial metastasis of thyroid follicular carcinoma: report of a case.
Yanjiao HU ; Lingling SUN ; Li DING ; Jingjing GUAN ; Dongliang LIN
Chinese Journal of Pathology 2014;43(5):336-337
Adenocarcinoma
;
metabolism
;
pathology
;
Adenocarcinoma, Follicular
;
metabolism
;
pathology
;
surgery
;
Bronchial Neoplasms
;
metabolism
;
secondary
;
surgery
;
Carcinoid Tumor
;
metabolism
;
pathology
;
DNA-Binding Proteins
;
metabolism
;
Diagnosis, Differential
;
Female
;
Humans
;
Middle Aged
;
Thyroglobulin
;
metabolism
;
Thyroid Neoplasms
;
metabolism
;
pathology
;
surgery
;
Transcription Factors
5.Expression of Twist in papillary thyroid carcinomas and its roles in differential diagnosis.
Chun-Nian HE ; Lili HE ; Jin Q CHENG ; Shi-Chao CHEN ; Huan-Fen ZHAO ; Jin-Ping ZHAI ; Jing ZHANG
Chinese Journal of Pathology 2008;37(1):35-39
OBJECTIVETo study Twist expression in thyroid papillary carcinoma (PTC) by immunohistochemistry and to assess its usefulness as marker in the differential diagnosis of PTC, follicular adenomas (FA) and benign papillary lesions (BPL).
METHODSFifty cases of PTC, 48 cases of FA and 47 cases of BPL were evaluated using manual tissue chip and SP immunohistochemical stain to detect the expression of Twist and HBME-1, and comparing the staining to that of cytokeratin 19 (CK19).
RESULTSIn PTC, positive rates of Twist, HBME-1 and CK19 were 100% (48/48), 94.0% (47/50) and 78.0% (39/ 50) respectively; in FA, positive rates were 0, 6.7% (3/45) and 0 respectively; in BPL, positive rates were 7.0% (3/34), 2.1% (1/47) and 0, respectively. The differences between PTC and FA and between PTC and BPL were both statistically significant (P = 0. 000). The sensitivity of Twist, HBME-1 and CK19 was 100%, 94.0% and 78.0%; the specifity was 96.4%, 95.7% and 100%; overall accurary was 97.7%, 95.1% and 91.9%, respectively.
CONCLUSIONSPositive rates of Twist is higher than the other markers in PTC. Immunohistochemical staining of Twist has important significance in the differential diagnosis of thyroid lesions. Twist immunohistochemistry maybe helpful in diagnosis and differential diagnosis of PTC.
Adenocarcinoma, Follicular ; metabolism ; Adenocarcinoma, Papillary ; pathology ; Adenoma ; diagnosis ; metabolism ; Biomarkers, Tumor ; immunology ; Carcinoma, Papillary ; diagnosis ; metabolism ; pathology ; Carcinoma, Papillary, Follicular ; metabolism ; Diagnosis, Differential ; Galectin 3 ; genetics ; metabolism ; Immunohistochemistry ; Keratin-19 ; genetics ; Keratins ; genetics ; metabolism ; Nuclear Proteins ; genetics ; metabolism ; Thyroid Neoplasms ; diagnosis ; metabolism ; pathology ; Thyroid Nodule ; pathology ; Twist-Related Protein 1 ; genetics ; metabolism
6.Pathologic features of recently identified renal cell carcinoma.
Xiang FAN ; Qiu RAO ; Li-hua ZHANG
Chinese Journal of Pathology 2013;42(8):569-573
Adenocarcinoma, Follicular
;
genetics
;
metabolism
;
pathology
;
Carcinoma, Papillary
;
genetics
;
metabolism
;
pathology
;
Carcinoma, Renal Cell
;
genetics
;
metabolism
;
pathology
;
Diagnosis, Differential
;
Humans
;
Immunohistochemistry
;
Kidney Diseases, Cystic
;
genetics
;
metabolism
;
pathology
;
Kidney Neoplasms
;
genetics
;
metabolism
;
pathology
;
Thyroid Neoplasms
;
genetics
;
metabolism
;
pathology
;
Translocation, Genetic
7.The advances of molecular pathology of follicular thyroid carcinoma.
Chinese Journal of Pathology 2004;33(3):268-270
Adenocarcinoma, Follicular
;
genetics
;
metabolism
;
pathology
;
Biomarkers, Tumor
;
genetics
;
Diagnosis, Differential
;
Humans
;
Matrix Metalloproteinase 1
;
biosynthesis
;
genetics
;
Telomerase
;
biosynthesis
;
genetics
;
Thyroid Neoplasms
;
genetics
;
metabolism
;
pathology
;
ras Proteins
;
biosynthesis
;
genetics
8.Clinicopathologic characteristics of primary thyroid-like follicular carcinoma in kidney.
Huan-wen WU ; Wen-jing CHEN ; Yan YOU ; Quan-cai CUI ; Tong-hua LIU
Chinese Journal of Pathology 2013;42(1):37-41
OBJECTIVETo explore the clinicopathological characteristics of primary thyroid-like follicular carcinoma of the kidney.
METHODSA case of primary thyroid-like follicular carcinoma of the kidney was studied with histology and immunohistochemical staining, and its clinical and pathological findings were further analyzed with review of the literature.
RESULTSThe patient was a 26-year-old asymptomatic woman who had a kidney mass during her annual physical examination. The tumor was well-circumscribed. Pathologically, the tumor showed follicular structures with colloid-like material in the lumina. Immunohistochemically, the tumor cells showed intense staining for CK7 and vimentin and negative for thyoid transcripation factor-1, thyroglobulin, thyoid peroxidase and RCC.
CONCLUSIONSThe diagnosis of primary thyroid-like follicular carcinoma of the kidney is based on the characteristic follicular architecture with colloid-like material, and the metastasis from a thyroid follicular carcinoma must be excluded clinically and pathologically before making the final diagnosis.
Adenocarcinoma, Follicular ; metabolism ; pathology ; Adult ; DNA-Binding Proteins ; metabolism ; Diagnosis, Differential ; Female ; Follow-Up Studies ; Humans ; Keratin-7 ; metabolism ; Kidney Neoplasms ; metabolism ; pathology ; Nephrectomy ; methods ; Neprilysin ; metabolism ; Thyroid Neoplasms ; metabolism ; pathology ; Transcription Factors ; Vimentin ; metabolism
9.Advances in poorly differentiated thyroid carcinoma.
Jian SUN ; Di YANG ; Quan-cai CUI
Chinese Journal of Pathology 2011;40(12):850-853
Adenocarcinoma, Follicular
;
epidemiology
;
genetics
;
metabolism
;
pathology
;
Carcinoma, Papillary
;
pathology
;
DNA-Binding Proteins
;
metabolism
;
Diagnosis, Differential
;
Genes, ras
;
genetics
;
Humans
;
Point Mutation
;
Prognosis
;
Thyroglobulin
;
metabolism
;
Thyroid Neoplasms
;
epidemiology
;
genetics
;
metabolism
;
pathology
;
Transcription Factors
10.Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses.
Xiao-Dong TENG ; Li-Jun WANG ; Hong-Tian YAO ; Jun LI ; Wei DING ; Li-Ping YAN
Chinese Journal of Pathology 2004;33(3):212-216
OBJECTIVETo study immunohistochemical expression of cytokeratin19 (CK19), galectin-3 (Gal-3) and HBME-1 in thyroid lesions and to assess their usefulness as markers in the differential diagnoses of thyroid nodular lesions.
METHODSImmunohistochemical staining was performed on formalin-fixed paraffin-embedded tissue of 21 cases of nodular goiters, 14 cases of toxic goiters, 15 cases of follicular adenomas (FA), 13 cases of follicular carcinomas (FC), 13 cases of follicular variant papillary carcinomas (FVPC) and 48 cases of classic papillary carcinomas (CPC).
RESULTSAll three markers were expressed in the cytoplasm with no or weak expression in benign lesions and diffuse and strong in malignant cases. Positive expressions of CK19, Gal-3 and HBME-1 were present in 11of 21, two of 21, four of 21 in nodular goiters, seven of 14, one of 14, one of 14 in toxic goiters, nine of 15, two of 15, two of 15 in FA, 10 of 13, eight of 13, seven of 13 in FC, 13 of 13, 11 of 13, 12 of 13 in FVPC, and 48 of 48, 45 of 48, 46 of 48 in CPC. The expression rates of the three markers between benign lesions (nodular goiters, toxic goiters and FA) and malignant lesions (FA, FVPC and CPC) were statistically significant. Among the three follicular lesions (FA, FC and FVPC), the differences were statistically significant as well. Nine, seven and six cases were negative for all three markers in nodular goiters, toxic goiters and FA, respectively. Only one case in FC was negative for all three markers, no case was all negative in FVPC and CPC; the rate of one case with two or more positive marker expression in nodular goiters, toxic goiters, FA, FC, FVPC and PC was 14.2% (3/21), 21.43% (3/14), 20.0% (3/15), 69.2% (9/13), 92.3% (12/13), 100.0% (48/48), the differences between benign lesions and malignant lesions and between FA, FC and FVPC were also statistically significant.
CONCLUSIONSImmunohistochemical stains of CK19, Gal-3 and HBME-1, especially when used in combination, can be an important adjunct to the histopathological diagnoses of thyroid lesions.
Adenocarcinoma, Follicular ; chemistry ; diagnosis ; pathology ; Adenoma ; chemistry ; diagnosis ; pathology ; Biomarkers, Tumor ; biosynthesis ; genetics ; Carcinoma, Papillary, Follicular ; pathology ; Diagnosis, Differential ; Galectin 3 ; biosynthesis ; genetics ; Goiter, Nodular ; metabolism ; pathology ; Humans ; Immunohistochemistry ; Keratins ; biosynthesis ; genetics ; Thyroid Neoplasms ; chemistry ; diagnosis ; pathology ; Thyroid Nodule ; chemistry ; diagnosis ; pathology